Suppr超能文献

[新生儿惊厥的治疗]

[Treatment of convulsions in newborn infants].

作者信息

Fischer K, Baarsma R

机构信息

Afd. Kindergeneeskunde, Academisch Ziekenhuis Beatrix Kinderkliniek, Groningen.

出版信息

Ned Tijdschr Geneeskd. 1996 Jul 27;140(30):1557-60.

PMID:8765765
Abstract

OBJECTIVE

Measurement of incidence of neonatal seizures and evaluation of the therapeutic strategy used.

SETTING

Neonatal intensive care unit, University Hospital, Groningen, the Netherlands.

DESIGN

Retrospective, descriptive.

METHODS

All patients admitted in a period of 5.5 years who had clinical seizures within 28 days from birth received pharmacological treatment in 4 steps. When a seizure remained clinically uncontrolled, the next step was taken. Step 1: methylphenobarbital 15-35 mg/kg i.v. Step 2: phenytoin 15-35 mg/kg i.v. After an initial loading dose of 15 mg/kg i.v., both the methylphenobarbital and the phenytoin loading dose were stepwise increased until reaching the maximum of 35 mg/kg. Step 3: clonazepam 1-2 x 0,15 mg/kg i.v. Step 4: thiopental 1-2 mg/kg/hour i.v.

RESULTS

The incidence of neonatal seizures was 121/2068 (5.9%). For assessment of the efficacy of the therapeutic strategy used, data of 37 patients were not available: 16 patients because of missing data, 11 because of deviation from the strategy and 10 because they died during the strategy. Cases of 84 patients could be evaluated for treatment response. The cumulative response rates were 68% (57/84) controlled seizures for methylphenobarbital, 87% (73/84) for phenytoin, 94% (79/84) for clonazepam, and 96% (81/84) for thiopental. For both methylphenobarbital and phenytoin a marked increase in clinical response was seen at increasing loading doses.

CONCLUSION

The stepwise therapeutic strategy used in this study proved to be successful in most cases of neonatal seizures. The anticonvulsive action of both methylphenobarbital and phenytoin appeared to be dose-related.

摘要

目的

测量新生儿惊厥的发病率并评估所采用的治疗策略。

地点

荷兰格罗宁根大学医院新生儿重症监护病房。

设计

回顾性、描述性研究。

方法

对5.5年内入院且出生后28天内出现临床惊厥的所有患者分4个步骤进行药物治疗。若惊厥在临床上仍未得到控制,则采取下一步治疗。步骤1:静脉注射甲基苯巴比妥15 - 35毫克/千克。步骤2:静脉注射苯妥英15 - 35毫克/千克。在初始静脉注射负荷剂量15毫克/千克后,甲基苯巴比妥和苯妥英的负荷剂量均逐步增加,直至达到最大剂量35毫克/千克。步骤3:静脉注射氯硝西泮1 - 2×0.15毫克/千克。步骤4:静脉注射硫喷妥钠1 - 2毫克/千克/小时。

结果

新生儿惊厥的发病率为121/2068(5.9%)。为评估所采用治疗策略的疗效,37例患者的数据不可用:16例因数据缺失,11例因偏离治疗策略,10例因在治疗过程中死亡。84例患者的病例可评估治疗反应。甲基苯巴比妥控制惊厥的累积有效率为68%(57/84),苯妥英为87%(73/84),氯硝西泮为94%(79/84),硫喷妥钠为96%(81/84)。甲基苯巴比妥和苯妥英在负荷剂量增加时,临床反应均显著增加。

结论

本研究中采用的逐步治疗策略在大多数新生儿惊厥病例中被证明是成功的。甲基苯巴比妥和苯妥英的抗惊厥作用似乎与剂量相关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验